FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286267517> ?p ?o ?g. }

• W4286267517 endingPage "114020" @default.
• W4286267517 startingPage "114020" @default.
• W4286267517 abstract "α-Synuclein (aSyn) is a protein implicated in physiological functions such as neurotransmitter release at the synapse and the regulation of gene expression in the nucleus. In addition, pathological aSyn assemblies are characteristic for a class of protein aggregation disorders referred to as synucleinopathies, where aSyn aggregates appear as Lewy bodies and Lewy neurites or as glial cytoplasmic inclusions. We recently discovered a novel post-translational pyroglutamate (pGlu) modification at Gln79 of N-truncated aSyn that promotes oligomer formation and neurotoxicity in human synucleinopathies. A priori, the appearance of pGlu79-aSyn in vivo involves a two-step process of free N-terminal Gln79 residue generation and subsequent cyclization of Gln79 into pGlu79. Prime candidate enzymes for these processes are matrix metalloproteinase-3 (MMP-3) and glutaminyl cyclase (QC). Here, we analyzed the expression of aSyn, MMP-3, QC and pGlu79-aSyn in brains of two transgenic mouse models for synucleinopathies (BAC-SNCA and ASO) by triple immunofluorescent labellings and confocal laser scanning microscopy. We report a co-localization of these proteins in brain structures typically affected by aSyn pathology, namely hippocampus in BAC-SNCA mice and substantia nigra in ASO mice. In addition, Western blot analyses revealed a high abundance of QC, MMP-3 and transgenic human aSyn in brain stem and thalamus but lower levels in cortex/hippocampus, whereas endogenous mouse aSyn was found to be most abundant in cortex/hippocampus, followed by thalamus and brain stem. During aging of ASO mice, we observed no differences between controls and transgenic mice in MMP-3 levels but higher QC content in thalamus of 6-month-old transgenic mice. Transgenic human aSyn abundance transiently increased and then showed decrease in oldest ASO mice analyzed. Immunohistochemistry revealed a successive increase in intraneuronal and extracellular formation of pGlu79-aSyn in substantia nigra during aging of ASO mice. Together, our data are supportive for a role of MMP-3 and QC in the generation of pGlu79-aSyn in brains affected by aSyn pathology." @default.
• W4286267517 created "2022-07-21" @default.
• W4286267517 creator A5005145881 @default.
• W4286267517 creator A5007270848 @default.
• W4286267517 creator A5015875427 @default.
• W4286267517 creator A5026782192 @default.
• W4286267517 creator A5027456029 @default.
• W4286267517 creator A5038246369 @default.
• W4286267517 creator A5040572132 @default.
• W4286267517 creator A5048371545 @default.
• W4286267517 creator A5058647332 @default.
• W4286267517 creator A5066105549 @default.
• W4286267517 creator A5088436295 @default.
• W4286267517 date "2022-09-01" @default.
• W4286267517 modified "2023-10-03" @default.
• W4286267517 title "Alpha synuclein processing by MMP-3 – implications for synucleinopathies" @default.
• W4286267517 cites W1486372353 @default.
• W4286267517 cites W1496790952 @default.
• W4286267517 cites W1514539285 @default.
• W4286267517 cites W1552912270 @default.
• W4286267517 cites W1606314433 @default.
• W4286267517 cites W1894541755 @default.
• W4286267517 cites W1964747897 @default.
• W4286267517 cites W1974145718 @default.
• W4286267517 cites W1978631965 @default.
• W4286267517 cites W1990632702 @default.
• W4286267517 cites W1995191747 @default.
• W4286267517 cites W1997895427 @default.
• W4286267517 cites W2011332000 @default.
• W4286267517 cites W2014856344 @default.
• W4286267517 cites W2016920663 @default.
• W4286267517 cites W2018225482 @default.
• W4286267517 cites W2018244586 @default.
• W4286267517 cites W2018631912 @default.
• W4286267517 cites W2022469979 @default.
• W4286267517 cites W2028578297 @default.
• W4286267517 cites W2032958786 @default.
• W4286267517 cites W2033836926 @default.
• W4286267517 cites W2042553854 @default.
• W4286267517 cites W2048383114 @default.
• W4286267517 cites W2056189919 @default.
• W4286267517 cites W2071359561 @default.
• W4286267517 cites W2073912959 @default.
• W4286267517 cites W2076798789 @default.
• W4286267517 cites W2080765656 @default.
• W4286267517 cites W2080949995 @default.
• W4286267517 cites W2083166775 @default.
• W4286267517 cites W2089791279 @default.
• W4286267517 cites W2089952709 @default.
• W4286267517 cites W2095253097 @default.
• W4286267517 cites W2108865709 @default.
• W4286267517 cites W2115713105 @default.
• W4286267517 cites W2121580577 @default.
• W4286267517 cites W2123869107 @default.
• W4286267517 cites W2137091415 @default.
• W4286267517 cites W2144134833 @default.
• W4286267517 cites W2161334375 @default.
• W4286267517 cites W2169324918 @default.
• W4286267517 cites W2306614385 @default.
• W4286267517 cites W2577340531 @default.
• W4286267517 cites W2587082207 @default.
• W4286267517 cites W2604479317 @default.
• W4286267517 cites W2615493985 @default.
• W4286267517 cites W2801998557 @default.
• W4286267517 cites W2906797028 @default.
• W4286267517 cites W2945531011 @default.
• W4286267517 cites W2946666527 @default.
• W4286267517 cites W2952794006 @default.
• W4286267517 cites W3007823431 @default.
• W4286267517 cites W3025486771 @default.
• W4286267517 cites W3106035494 @default.
• W4286267517 cites W3119882179 @default.
• W4286267517 cites W3165115994 @default.
• W4286267517 cites W3185892560 @default.
• W4286267517 cites W3194492754 @default.
• W4286267517 doi "https://doi.org/10.1016/j.bbr.2022.114020" @default.
• W4286267517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35870616" @default.
• W4286267517 hasPublicationYear "2022" @default.
• W4286267517 type Work @default.
• W4286267517 citedByCount "3" @default.
• W4286267517 countsByYear W42862675172023 @default.
• W4286267517 crossrefType "journal-article" @default.
• W4286267517 hasAuthorship W4286267517A5005145881 @default.
• W4286267517 hasAuthorship W4286267517A5007270848 @default.
• W4286267517 hasAuthorship W4286267517A5015875427 @default.
• W4286267517 hasAuthorship W4286267517A5026782192 @default.
• W4286267517 hasAuthorship W4286267517A5027456029 @default.
• W4286267517 hasAuthorship W4286267517A5038246369 @default.
• W4286267517 hasAuthorship W4286267517A5040572132 @default.
• W4286267517 hasAuthorship W4286267517A5048371545 @default.
• W4286267517 hasAuthorship W4286267517A5058647332 @default.
• W4286267517 hasAuthorship W4286267517A5066105549 @default.
• W4286267517 hasAuthorship W4286267517A5088436295 @default.
• W4286267517 hasConcept C102230213 @default.
• W4286267517 hasConcept C104317684 @default.
• W4286267517 hasConcept C141035611 @default.
• W4286267517 hasConcept C142724271 @default.
• W4286267517 hasConcept C169760540 @default.

• next